Mucosal Vaccines Adjuvants

Mucosal immune responses are the first-line defensive mechanisms against a variety of infections. Consequently, immunizations of mucosal surfaces from which common of infectious agents make their entry, helps to protect the body against infections. Hence, vaccination of mucosal surfaces by using mucosal vaccines delivers the basis for generating protective immunity both in the mucosal and systemic immune compartments.Vaccines delivered through mucosal surfaces are increasingly studied because of their properties to effectively induce mucosal immune responses are cheap, easily administrable and suitable for mass vaccinations.

Mucosal vaccination, capable of inducing protective immune responses both in the mucosal and systemic immune compartments generally induction of immune responses following mucosal immunization requires the co-administration of appropriate adjuvants that can initiate and support the effective collaboration between innate and adaptive immunity.

  • Immune Mechanisms of Adjuvant Action
  • Selected Adjuvants and Immunostimulation
  • Mucosal Immunity versus Tolerance
  • Future Perspectives

Related Conference of Mucosal Vaccines Adjuvants

November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE
April 19-20, 2018

7th World Congress on Immunology

Amsterdam, Netherlands
May 28-29, 2018

World Congress on Allergy and Immunotherapy

Osaka, Japan

9th European Immunology Conference

June 14-16, 2018 Rome, Italy
July 05-07, 2018

EuroSciCon Conference on Immunology Conference 2018

Vienna, Austria
July 12-13, 2018

5th International Conference on Parasitology

Paris, France

Mucosal Vaccines Adjuvants Conference Speakers

Recommended Sessions

Related Journals

Are you interested in